![Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots | Fierce Pharma Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1609773940/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=X1bK1thCrsIJToWd7af0EHDVbJxw8wf4)
Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots | Fierce Pharma
![NACI recommends AstraZeneca first dose recipients to get Pfizer, Moderna vaccines for second shot | CP24.com NACI recommends AstraZeneca first dose recipients to get Pfizer, Moderna vaccines for second shot | CP24.com](https://beta.cp24.com/content/dam/cp24/videos/axis/2021/6/17/2224865/_jcr_content/renditions/videothumbnail.1623972078584.jpg)
NACI recommends AstraZeneca first dose recipients to get Pfizer, Moderna vaccines for second shot | CP24.com
![Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet](https://www.thelancet.com/cms/attachment/7694a6c8-72cc-4d1e-b5c0-6ecdba85f623/gr1_lrg.jpg)
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
![Coronavirus: AstraZeneca-Oxford developer blasts Canada's approach to vaccine, says 'messing around is going to cost lives' | CTV News Coronavirus: AstraZeneca-Oxford developer blasts Canada's approach to vaccine, says 'messing around is going to cost lives' | CTV News](https://beta.ctvnews.ca/content/dam/ctvnews/images/2021/5/16/1_5326913.jpg?cache_timestamp=1621168464540)
Coronavirus: AstraZeneca-Oxford developer blasts Canada's approach to vaccine, says 'messing around is going to cost lives' | CTV News
![Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet](https://www.thelancet.com/cms/asset/643af9b2-1d35-4487-bda0-687f2e80ab01/gr1.jpg)